产品介绍
戊型病毒性肝炎是一种自愈性传染病，其传播方式、临床表现和预后均与甲型肝炎(甲肝)类似，孕妇患戊肝病死率高为本型肝炎的特点。
|
EV64
|
rAg
|
|
E.coli
|
包被/标记
|
酶免、发光、层析
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human CD40/TNFRSF5 Recombinant Antibody, FITC|抗人CD40/TNFRSF5重组抗体，FITC(靶标：人CD40) |
421 |
| Anti-Human CD40/TNFRSF5 Recombinant Antibody , FITC|抗人CD40/TNFRSF5重组抗体，FITC(靶标：人CD40) |
180 |
| Anti-Human CD40/TNFRSF5 Recombinant Antibody , FITC|抗人CD40/TNFRSF5重组抗体，FITC(靶标：人CD40) |
272 |
| Anti-Human CD40/TNFRSF5 Recombinant Antibody , FITC|抗人CD40/TNFRSF5重组抗体，FITC(靶标：人CD40) |
305 |
| Anti-Mouse CD40/TNFRSF5 Recombinant Antibody, FITC|抗小鼠CD40/TNFRSF5重组抗体，FITC(靶标：小鼠CD40) |
200 |
| Anti-Human CD49c/ITGA3 Recombinant Antibody, FITC|抗人CD49c/ITGA3重组抗体，FITC(靶标：人CD49c（整合素α3）) |
332 |
| Anti-Human CD159a/KLRC1 Recombinant Antibody, FITC|抗人CD159a/KLRC1重组抗体，FITC(靶标：人NKG2A（CD159a）) |
174 |
| Anti-Human CD159a/KLRC1 Recombinant Antibody, FITC|抗人CD159a/KLRC1重组抗体，FITC(靶标：人NKG2A（CD159a）) |
489 |
| Anti-Human CD314/KLRK1 Recombinant Antibody , FITC|抗人CD314/KLRK1重组抗体，FITC(靶标：人NKG2D（CD314）) |
283 |
| Anti-Mouse NKG2D Recombinant Antibody, FITC|抗小鼠NKG2D重组抗体，FITC(靶标：小鼠NKG2D) |
199 |
| Anti-Mouse NKG2D Recombinant Antibody, FITC|抗小鼠NKG2D重组抗体，FITC(靶标：小鼠NKG2D) |
385 |
| Anti-Human CD27 Recombinant Antibody, FITC|抗人CD27重组抗体，FITC(靶标：人CD27) |
430 |
| Anti-Human CD27 Recombinant Antibody, FITC|抗人CD27重组抗体，FITC(靶标：人CD27) |
483 |
| Anti-Human CD123/IL3RA Recombinant Antibody , FITC|抗人CD123/IL3RA重组抗体，FITC(靶标：人IL-3受体α亚基) |
232 |
| Anti-Human ACVR2A & ACVR2B Recombinant Antibody , FITC|抗人ACVR2A和ACVR2B重组抗体，FITC(靶标：人激活素受体IIA/IIB) |
329 |
| Anti-Human CD26/DPP4 Recombinant Antibody , FITC|抗人CD26/DPP4重组抗体，FITC(靶标：人CD26（二肽基肽酶IV）) |
450 |
| Anti-Mouse CD26/DPP4 Recombinant Antibody, FITC|抗小鼠CD26/DPP4重组抗体，FITC(靶标：小鼠CD26（二肽基肽酶IV）) |
356 |
| Anti-Rat CD26/DPP4 Recombinant Antibody , FITC|抗大鼠CD26/DPP4重组抗体，FITC(靶标：大鼠CD26（二肽基肽酶IV）) |
309 |
| Anti-Human Calreticulin/CALR Recombinant Antibody , FITC|抗人钙网蛋白/CALR重组抗体，FITC(靶标：人钙网蛋白) |
353 |
| Mouse IgA Recombinant Isotype Control Antibody, FITC|小鼠IgA重组同型对照抗体，FITC(靶标：小鼠免疫球蛋白A) |
321 |
